Translational Studies of Fn14 in Brain Tumors

描述（由申请人提供）：多形性胶质母细胞瘤是最常见的原发性恶性脑肿瘤，由于其局部侵袭邻近正常脑组织的倾向和全身转移的罕见性，其生物学独特。侵袭性胶质瘤细胞的潜在特异性治疗靶点尚未确定：然而，这些靶点的成功鉴定将有望催化新疗法的开发。我们已经证明，Fn14的表达是最小的，在正常脑组织中不存在，但随着肿瘤分级的增加而增加。通过添加重组TWEAK或过表达Fn14激活Fn14信号传导增强胶质瘤细胞运动性和存活。我们假设Fn14的活性增强恶性胶质母细胞瘤细胞的存活和向正常脑实质的侵袭。干扰Fn14的功能可能会特异性靶向侵袭性胶质母细胞瘤细胞，并影响肿瘤复发的能力。这一假设将通过追求以下具体目标进行测试：1。确定Fn14信号传导的体外抑制是否使胶质瘤细胞对细胞毒性疗法敏感。将通过siRNA、小抑制分子和显性阴性构建体对Fn14信号级联进行操作，以评估临床细胞毒性剂对多种胶质瘤细胞系和原代低传代细胞株中细胞凋亡诱导的影响。2. Fn14在胶质瘤侵袭中的作用Fn14在神经胶质瘤侵袭中的作用将使用离体脑切片器官型基质和将人神经胶质瘤细胞原位异种移植到免疫受损大鼠的大脑中来评估。此外，Fn14和信号蛋白的水平将与肿瘤分级和使用免疫组织化学对含有人脑肿瘤的组织微阵列的侵袭模式相关。了解Fn14在胶质瘤迁移和细胞存活的背景下，将提供一个更深入的了解恶性胶质母细胞瘤的恶性进展和侵袭性表型的分子机制。这些研究的结果将描述Fn 14作为治疗干预靶点的适用性和适用性。

DESCRIPTION (provided by applicant): Glioblastomas multiforme is the most common primary malignant brain tumor, biologically unique by virtue of their proclivity for local invasion into the adjacent normal brain tissue and the rarity of systemic metastasis. Potential specific therapeutic targets for invasive glioma cells have vet to be identified: however, the successful identification of these targets would be anticipated to catalyze development of novel therapies. We have demonstrated that Fn14 expression is minimal-to-absent in normal brain tissue but increases with increasing tumor grade. Activation of Fn14 signaling by addition of recombinant TWEAK or over-expression of Fn14 enhances glioma cell motility and survival. We HYPOTHESIZE that the activity of Fn14 enhances malignant glioblastoma cell survival and invasion into the normal brain parenchyma. Interfering with the function of Fn14 is likely to specifically target invasive glioblastoma cells and impact the ability of the tumor to recur. This hypothesis will be tested by pursuing the following specific aims: 1. Determine whether the in vitro inhibition of Fn14 signaling sensitizes glioma cells to cytotoxic therapy. Manipulation of the Fn14 signaling cascade by siRNA, small inhibitory molecules, and dominant negative constructs will be performed to assess the effects on apoptosis induction by clinical cytotoxic agents in multiple glioma cell lines and primary low passage cell strains. 2. Determine the function of Fn14 in glioma invasion in vivo. The role of Fn14 in glioma invasion will be assessed using an ex vivo brain slice organotypic substrate and xenografting of human glioma cells orthotopically into the cerebrum of immunocompromised rats. In addition, levels of Fn14 and signaling proteins will be correlated with tumor grade and patterns of invasion using immunohistochemistry on tissue microarrays containing human brain tumors. Understanding Fn14 in the context of glioma migration and cell survival will provide a more thorough insight into malignant progression of glioblastoma and the molecular mechanisms of the invasive phenotype. The results from these studies will profile the suitability and applicability of Fn 14 as a target for therapeutic intervention.